![](https://focusbankers.com/wp-content/uploads/2023/07/OPHTHALMOLOGY-article-image-1.png)
![](https://focusbankers.com/wp-content/uploads/2023/04/OPHTHALMOLOGY-article-image-v2.png)
The ophthalmology sector continues to be a robust market entering Q2 2023. There are more than 25 core private equity platforms within ophthalmology, plus smaller regional PE-backed groups. Read more here.
The ophthalmology sector continues to be a robust market entering Q2 2023. There are more than 25 core private equity platforms within ophthalmology, plus smaller regional PE-backed groups. Read more here.